Skip to content

Stand By Me: Anti-Drug Elite Adventure-Based Training Program

Stand By Me: Anti-Drug Elite Adventure-Based Training Program

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07064343
Enrollment
200
Registered
2025-07-14
Start date
2024-09-09
Completion date
2025-09-08
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse Prevention

Keywords

Health Promotion, Drug Abusers, The AWARD model, Adventure-based Training Program

Brief summary

This project is expected to establish a network of resilient young people with good anti-drug knowledge to mobilize them to assist in current or future anti-drug work, expanding the antidrug capacity of our community. After the project, it is also anticipated that people in this network will continue to assist in the anti-drug work.

Detailed description

In phase 1, the investigators will deliver adventure-based training programs (2-day 1-night camp). Participants will attend in the educational workshop and undergo five adventure-based activities. The key educational workshop's topics include: 1) introduction to the drugs, health and legal consequences of drugs especially cocaine, cannabis and ice, 2) anti-drug services, and 3) the AWARD model.

Interventions

OTHERAspirin

Participants are required to complete the training program includes an educational workshops and five adventure-based activities. The key educational workshop's topics include: 1) introduction to the drugs, health and legal consequences of drugs especially cocaine, cannabis and ice, 2) anti-drug services, and 3) the AWARD model.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. post-secondary or tertiary education students, 2. aged 18 - 35, 3. able to speak in Cantonese and write in Chinese.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
BDF Question Set No. 2Baseline and 2 days (pre and post intervention)To assess knowledge about the harm of drug abuse. Scoring Instruction: Q1 + Q2 + Q3 + Q4 + Q5 + (6-Q6) + Q7 + Q8 + Q9 + Q10. Minimum score: 10 Maximum score: 50.
BDF Question Set No. 24baseline and 2 days (pre and post intervention)Knowledge about Cannabis-related Harms. Minimum score: 12 Maximum score: 60. total score calculate: Q1 + Q2 + Q3 + Q4 + Q5 + Q6 + Q7+ Q8 + Q9 + Q10 + (6-Q11) + (6-Q12).
BDF Question Set No. 18Baseline and 2 days (pre and post intervention)To assess permissive attitude towards drug abuse (Secondary school student version). Minimum score: 21 Maximum score: 105. Total scores calculate: Q1 + Q2 + Q3 + Q4 + Q5 + Q6 + Q7 + Q8 + Q9 + Q10 + Q11 + Q12 + Q13 + Q14 + Q15 + Q16 + Q17 + Q18 + Q19 + Q20 + Q21.
BDF Question Set No. 25baseline and 2 days (pre and post intervention)To assess permissive attitude towards smoking cannabis. Minimum score: 13 Maximum score: 65. Calculate process: Q1 + Q2 + Q3 + Q4 + Q5 + Q6 + Q7+ Q8 + Q9 + Q10 + Q11 + Q12 + Q13.
BDF Question Set No. 26Baseline and 2 days (pre and post intervention)To assess permissive attitude towards drugs trafficking. Minimum score: 14 Maximum score: 70. Total scores calculate: Q1 + Q2 + (6-Q3) + Q4 + (6-Q5) + Q6 + (6-Q7) + (6-Q8) + Q9 + Q10 + (6-Q11) + Q12 + Q13.
The Chinese version of the 14-item resilience scaleBaseline and 2 days (pre and post intervention)The 14-item resilience scale (RS-14) was used to assess the degree of resilience and was a short version of the original resilience scale (RS). The RS-14 was a 14-item and single-factor structure instrument, comprising a 7-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). Examples of the items were, I feel that I can handle many things at a time and I keep interested in things. The Chinese translation of the RS-14 was developed with a backtranslation procedure to ensure accuracy. Suitable internal consistency was suggested by a figure of .917 for the coefficient alpha (regarding the RS-14 of the original scale). Further, the original RS-14 was retested after three weeks, and the test-retest reliability of RS-14 was .736 (.595, .837).

Countries

Hong Kong

Contacts

Primary ContactKa Wai Katherine Lam
kw-katherine.lam@polyu.edu.hk27666420
Backup ContactKa Yan Ho
kyeva.ho@polyu.edu.hk2766417

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026